FolioLanternBeta
AEHRAehr Test Systems

Laura Oliphant

Director at Aehr Test Systems, as of Aug 13, 2026Sold $1.1M of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
16K
shares held after the latest filing, Aehr Test Systems
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
16K
shares sold, past 12 months
4
days with sales
$539K
largest single day, Apr 16, 2026
1
company filed for

Share of stake sold at Aehr Test Systems is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJan 2026: $143K no plan disclosedJanFebMarApr 2026: $744K no plan disclosed$744KAprMayJunJulAug 2026: $228K no plan disclosedAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Aehr Test Systems (AEHR)DirectorJul 23, 2019Aug 13, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.